Literature DB >> 7820021

MR findings of hepatic cavernous hemangioma after intraarterial infusion of iodized oil.

B I Choi1, Y M Shin, J W Chung, S H Kim, J H Park, M C Han.   

Abstract

Magnetic resonance (MR) imaging was performed on five tumors of three patients who had hepatic hemangiomas. Four tumors were given an intraarterial infusion of 3-8 ml of iodized oil, while one tumor was not. MR images were obtained at 2.0 or 0.5 T. A single spin echo sequence with TE of 30 ms and TR of 500 ms and a double echo sequence with TEs of 60 and 150 ms and TR of 2000 ms, were used to produce relatively T1-, T2-weighted, and heavily T2-weighted images, respectively. Follow-up MR imaging was done 1-5 months after infusion of iodized oil. On relatively T1-weighted images, hemangiomas showed iso- or hypointensity. On T2-weighted images, all tumors showed hyperintensity. However, on heavily T2-weighted images, tumors with iodized oil showed heterogeneous, slight hyperintensity, while tumors without iodized oil showed characteristic appearance of marked hyperintensity in hemangiomas. In hepatic cavernous hemangiomas with intraarterial infusion of iodized oil, familiarity with this unusual MR intensity of tumors on heavily T2-weighted images is useful to avoid the incorrect diagnosis and to reduce the frequency of inappropriate hepatic resection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7820021     DOI: 10.1007/bf00198251

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  19 in total

1.  Small hepatocellular carcinoma versus small cavernous hemangioma: differentiation with MR imaging at 2.0 T.

Authors:  B I Choi; M C Han; C W Kim
Journal:  Radiology       Date:  1990-07       Impact factor: 11.105

2.  Iodine-131-labeled lipiodol retention within hepatic cavernous hemangioma.

Authors:  C H Park; J H Suh; H S Yoo; J T Lee; D I Kim; K S Lee
Journal:  Radiology       Date:  1987-04       Impact factor: 11.105

3.  Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m-labeled red blood cell SPECT.

Authors:  B A Birnbaum; J C Weinreb; A J Megibow; J J Sanger; E Lubat; H Kanamuller; M E Noz; M A Bosniak
Journal:  Radiology       Date:  1990-07       Impact factor: 11.105

4.  Differentiation between small hepatic hemangiomas and metastases on MR images: importance of size-specific quantitative criteria.

Authors:  K Itoh; S Saini; P F Hahn; N Imam; J T Ferrucci
Journal:  AJR Am J Roentgenol       Date:  1990-07       Impact factor: 3.959

5.  Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents.

Authors:  K Takayasu; Y Shima; Y Muramatsu; N Moriyama; T Yamada; M Makuuchi; H Hasegawa; S Hirohashi
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

6.  Hepatocellular carcinoma detected by iodized oil.

Authors:  Y Yumoto; K Jinno; K Tokuyama; Y Araki; T Ishimitsu; H Maeda; T Konno; S Iwamoto; K Ohnishi; K Okuda
Journal:  Radiology       Date:  1985-01       Impact factor: 11.105

7.  Distinction of hepatic cavernous hemangioma from hepatic metastases with MR imaging.

Authors:  K C Li; G M Glazer; L E Quint; I R Francis; A M Aisen; W D Ensminger; F L Bookstein
Journal:  Radiology       Date:  1988-11       Impact factor: 11.105

8.  Noninvasive diagnosis of small cavernous hemangioma of the liver: advantage of MRI.

Authors:  Y Itai; K Ohtomo; S Furui; T Yamauchi; M Minami; N Yashiro
Journal:  AJR Am J Roentgenol       Date:  1985-12       Impact factor: 3.959

9.  Hepatic cavernous hemangioma: magnetic resonance imaging. Work in progress.

Authors:  G M Glazer; A M Aisen; I R Francis; J W Gyves; I Lande; D D Adler
Journal:  Radiology       Date:  1985-05       Impact factor: 11.105

10.  Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization.

Authors:  D D Stark; R C Felder; J Wittenberg; S Saini; R J Butch; M E White; R R Edelman; P R Mueller; J F Simeone; A M Cohen
Journal:  AJR Am J Roentgenol       Date:  1985-08       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.